Who is sponsoring NCT06872775?

NCT06872775 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT06872775?

Interventions in NCT06872775: Blood draws to assess RNA expression levels.

What condition does NCT06872775 study?

NCT06872775 studies Fractures, Bone.

Is NCT06872775 still recruiting?

NCT06872775 is currently enrolling by invitation. Last updated 16 January 2026.

Last reviewed 2026-01-16 · How we verify

NCT06872775: 855303-RNAVal

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

855303-RNA Biomarker Validation

ENROLLING BY INVITATION Last updated 16 January 2026

What this trial tests

trial testing Blood draws to assess RNA expression levels in Fractures, Bone in 110 participants. Enrolling by invitation.

Timeline

25 August 2025

Primary endpoint
24 August 2028

24 August 2028

Quick facts

Lead sponsor	University of Pennsylvania
Status	ENROLLING BY INVITATION
Study type	OBSERVATIONAL
Enrollment	110
Start date	25 August 2025
Primary completion	24 August 2028
Estimated completion	24 August 2028
Sites	7 locations across United States

Drugs / interventions tested

Blood draws to assess RNA expression levels

Conditions studied

Fractures, Bone — all drugs for Fractures, Bone →

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Fractures, Bone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test the accuracy of using RNA in blood as a way to forecast new fracture healing outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fractures, Bone

Currently open trials in the same condition.

NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
NCT06754137 — Assessing AI-Supported Fracture Detection in Emergency Care Units · NA · recruiting
NCT06113211 — Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures · Phase 4 · recruiting
NCT06013852 — Boneview-ED - Impact of Artificial Intelligence Detecting Fractures in the Emergence Department : a Pragmatic Prospectiv · NA · recruiting
NCT06256458 — Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06872775 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 16 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06872775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing